Scientific publications

SUDOSCAN in Oncology : Chemotherapy Induced Polyneuropathy

Oncology, Scientific publications / By

SUDOSCAN in Oncology : Chemotherapy InduCed Polyneuropathy Two studies evaluating SUDOSCAN Severe drug-induced neurotoxic adverse effects constitute the second most common cause of dose limitation after haematological adverse effects.  Chemotherapy Induced Polyneuropathy (CIPN) is commonly associated with platinum analogues, antitubulins (taxane), the proteasome inhibitor bortezomib, and thalidomide. However, it is poorly investigated at an early …

SUDOSCAN in Oncology : Chemotherapy Induced Polyneuropathy Read More »

EASD 2019 poster: diabetic foot risk detection with SUDOSCAN

Diabetes, Events, News, Scientific publications / By

EASD 2019 POSTER:DIABETIC FOOT RISK DETECTION A multi-center study (3 hospitals: Bichat, La Pitié Salpêtrière, Bégin) completed in France established the link between the grade of diabetic foot risk and the decrease of Electrochemical Skin Conductance (ESC) measured with SUDOSCAN. A poster has been presented at the European Association for the Study of Diabetes (EASD) …

EASD 2019 poster: diabetic foot risk detection with SUDOSCAN Read More »

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

To receive our latest scientific news:

Website dedicated
to health professionals

I am a health professional

Scroll to Top